https://assets1b.milkeninstitute.org/assets/Publication/Rese...
As far as it’s implications on the cost of healthcare in the US I don’t think there is data for it since it’s pretty hard to measure.
I agree, it’s hard to measure, but do you think those estimates are more than 3% off?
Best case, eliminating all drug research saves you 10%.
Although if costs in other areas are bloated, that is a scarier number. [1] https://www.cms.gov/research-statistics-data-and-systems/sta...
What I am getting at is that in theory, it should still be possible to do a lot of great R&D work while still providing affordable health care to citizens. I don’t think they are necessarily tied together.
Also more patents is not necessarily a good thing since they can create more legal hurdles and red tape for other pharmaceutical companies who may want to build on top of the ideas and inventions.
The US is also 40% or so of the global pharmaceutical market given its population it literarily funds the profits of the global pharmaceutical industry doesn’t matter if it’s American Swiss or Indian company they all make their buck on the back of Uncle Sam. It’s not clear what the impact would be if the US would say start paying 50% less for health care on the world.